Related references
Note: Only part of the references are listed.AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors
M. Vittoria Spampinato et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Histological classification and molecular genetics of meningiomas
Markus J. Riemenschneider et al.
LANCET NEUROLOGY (2006)
Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: A relationship among efficacy, joint toxicity and anticonvulsant status
Morris D. Groves et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Expression of hypoxia-inducible factor-1 and vascular endothelial growth factor in response to venous hypertension
Yiqian Zhu et al.
NEUROSURGERY (2006)
Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain
Justin G. Santarelli et al.
NEUROSURGERY (2006)
New vessel formation in the central nervous system during tumor growth, vascular malformations, and Moyamoya
Michael Lim et al.
CURRENT NEUROVASCULAR RESEARCH (2006)
Genetics of cerebral cavernous angioma
U. Felbor et al.
ZENTRALBLATT FUR NEUROCHIRURGIE (2006)
Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: A North American Brain Tumor Consortium study
Timothy F. Cloughesy et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of north central cancer treatment group protocol N0177
Sunil Krishnan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas
L. Doherty et al.
NEUROLOGY (2006)
In vivo tumor angiogenesis imaging with site-specific labeled 99mTc-HYNIC-VEGF
Francis G. Blankenberg et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation
Victor A. Levin et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: A second reference standard in the surgical and nonsurgical treatment of low-grade gliomas
Meng Law et al.
NEUROSURGERY (2006)
Contrast/noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas
Nicolas Fayed et al.
ACADEMIC RADIOLOGY (2006)
Targeted imaging of human endothelial-specific marker in a model of adoptive cell transfer
Hye Won Kang et al.
LABORATORY INVESTIGATION (2006)
Transplanted glioma cells migrate and proliferate on host brain vasculature: A dynamic analysis
A Farin et al.
GLIA (2006)
Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization
C Colin et al.
ONCOGENE (2006)
Different angiogenic phenotypes in primary and secondary glioblastomas
S Karcher et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Phase 1 trial of gefitinib plus sirolimus in adults with recurrent malignant glioma
DA Reardon et al.
CLINICAL CANCER RESEARCH (2006)
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer
P. K. Y. Goon et al.
NEOPLASIA (2006)
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma
MD Prados et al.
NEURO-ONCOLOGY (2006)
Distinct transcription profiles of primary and secondary glioblastoma subgroups
CL Tso et al.
CANCER RESEARCH (2006)
Angiogenesis as a therapeutic target
N Ferrara et al.
NATURE (2005)
Contribution of bone marrow-derived cells to blood vessels in ischemic tissues and tumors
M Aghi et al.
MOLECULAR THERAPY (2005)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
IK Mellinghoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The role of pericytes in blood-vessel formation and maintenance
G Bergers et al.
NEURO-ONCOLOGY (2005)
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
R Abounader et al.
NEURO-ONCOLOGY (2005)
Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: A north central cancer treatment group study
E Galanis et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
SM Chang et al.
INVESTIGATIONAL NEW DRUGS (2005)
Metalloproteinases and their inhibitors in tumor angiogenesis
MM Handsley et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
MRS of oligodendroglial tumors - Correlation with histopathology and genetic subtypes
MD Jenkinson et al.
NEUROLOGY (2005)
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
DA Haas-Kogan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
αvβ3 integrin in central nervous system tumors
M Lim et al.
HUMAN PATHOLOGY (2005)
Difficult diagnostic cases -: Case 2.: Hemangioblastomas:: Diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416
G Schuch et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Circulating endothelial progenitor cells in multiple myeloma:: implications and significance
H Zhang et al.
BLOOD (2005)
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
DJ Brat et al.
NEURO-ONCOLOGY (2005)
Contribution of bone marrow-derived endothelial cells to human tumor vasculature
BA Peters et al.
NATURE MEDICINE (2005)
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model
SA Anderson et al.
BLOOD (2005)
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma
U Herrlinger et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme
J Tuettenberg et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme
F Baumann et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Antiangiogenic therapy for von Hippel-Lindau disease
S Madhusudan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population
DJ Brat et al.
CANCER RESEARCH (2004)
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett et al.
NATURE MEDICINE (2004)
Stabilization of a progressive hemangioblastoma under treatment with thalidomide
M Piribauer et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Vascular targeting agents as cancer therapeutics
PE Thorpe
CLINICAL CANCER RESEARCH (2004)
Phase II study of temozolomide and thalidomide with radiation therapy for newly diagnosed glioblastoma multiforme
SM Chang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors
E Peles et al.
NEUROSURGERY (2004)
Incorporation of naive bone marrow derived cells into the vascular architecture of brain tumor
YC Yung et al.
MICROCIRCULATION (2004)
Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial
NS Akella et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2004)
Vascular-targeting therapies for treatment of malignant disease
DW Siemann et al.
CANCER (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Suramin and radiotherapy in newly diagnosed glioblastoma: Phase 2 NABTT CNS Consortium study
JJ Laterra et al.
NEURO-ONCOLOGY (2004)
Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients
LV Beerepoot et al.
ANNALS OF ONCOLOGY (2004)
Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion
AC Bellail et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Genetic and hypoxic regulation of angiogenesis in gliomas
B Kaur et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Phase II trial of gefitinib in recurrent glioblastoma
JN Rich et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel et al.
NATURE REVIEWS CANCER (2004)
HIF-1 and p53:: communication of transcription factors under hypoxia
T Schmid et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2004)
Genetic pathways to glioblastoma:: A population-based study
H Ohgaki et al.
CANCER RESEARCH (2004)
Endothelial progenitor cells' 'homing' specificity to brain tumors
XL Moore et al.
GENE THERAPY (2004)
Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood
B Gesundheit et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2003)
PTEN methylation and expression in glioblastomas
N Baeza et al.
ACTA NEUROPATHOLOGICA (2003)
Angiogenesis in endocrine tumors
HE Turner et al.
ENDOCRINE REVIEWS (2003)
Preliminary observations on genetic alterations in pilocytic astrocytomas associated with neurofibromatosis 1
K Tada et al.
NEURO-ONCOLOGY (2003)
Angiogenic factors in the central nervous system
MR Harrigan
NEUROSURGERY (2003)
Circulating numbers of endothelial progenitor cells in patients with gastric and breast cancer
HK Kim et al.
CANCER LETTERS (2003)
Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2
B Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas
JF Girmens et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas
HA Fine et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Basement membranes: Structure, assembly and role in tumour angiogenesis
R Kalluri
NATURE REVIEWS CANCER (2003)
Vasculogenic mimicry and tumour-cell plasticity: Lessons from melanoma
MJC Hendrix et al.
NATURE REVIEWS CANCER (2003)
Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells
M De Palma et al.
NATURE MEDICINE (2003)
Tumor response to radiotherapy regulated by endothelial cell apoptosis
M Garcia-Barros et al.
SCIENCE (2003)
Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: Correlation with histopathology
S Cha et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Continuous growth of mean tumor diameter in a subset of grade II gliomas
E Mandonnet et al.
ANNALS OF NEUROLOGY (2003)
Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors
N Ferrari et al.
GENE THERAPY (2003)
Hydrogen-1 MR spectroscopy of the peritumoral zone in patients with cerebral glioma:: Assessment of the value of the method
J Walecki et al.
ACADEMIC RADIOLOGY (2003)
Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging
M Rijpkema et al.
NMR IN BIOMEDICINE (2003)
Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy
FA Howe et al.
MAGNETIC RESONANCE IN MEDICINE (2003)
Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression
B Kaur et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Dynamic contrast-enhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: Results from two phase I studies
B Morgan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Strategies to investigate circulating endothelial cells in cancer
P Mancuso et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2003)
Phase II study of high central dose gamma knife radiosurgery and marimastat in patients with recurrent malignant glioma
DA Larson et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Vascular and haematopoietic stem cells:: Novel targets for anti-angiogenesis therapy?
S Rafii et al.
NATURE REVIEWS CANCER (2002)
Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry
EA Seftor et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: Preliminary results
JH Shin et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2002)
Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelia growth factor receptor inhibitor SU5416
LP Aiello et al.
OPHTHALMOLOGY (2002)
Clinical impact and functional aspects of tenascin-C expression during glioma progression
C Herold-Mende et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse
ZG Zhang et al.
CIRCULATION RESEARCH (2002)
Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry
N Sharma et al.
PROSTATE (2002)
Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas
E Passalidou et al.
BRITISH JOURNAL OF CANCER (2002)
Functional and molecular MR imaging of angiogenesis: Seeing the target, seeing it work
M Neeman
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
The WHO classification of tumors of the nervous system
P Kleihues et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al.
NATURE MEDICINE (2001)
Collateral growth and angiogenesis around cortical stroke
L Wei et al.
STROKE (2001)
Phase II study of Thalidomide in the treatment of recurrent glioblastoma multiforme
GM Marx et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Abnormal balance in the angiopoietin-Tie2 system in human brain arteriovenous malformations
T Hashimoto et al.
CIRCULATION RESEARCH (2001)
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
P Mancuso et al.
BLOOD (2001)
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells
K Hattori et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain
M Kaminogo et al.
NEURORADIOLOGY (2001)
PTEN controls tumor-induced angiogenesis
SH Wen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A pilot trial of vitaxin, a humanized anti-vitronectin receptor (anti αvβ3) antibody in patients with metastatic cancer
JA Posey et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2001)
Vascular growth factors in cerebral ischemia
SD Croll et al.
MOLECULAR NEUROBIOLOGY (2001)
Thalidomide as an anti-angiogenic agent in relapsed gliomas
SC Short et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas
Y Cheng et al.
HISTOPATHOLOGY (2000)
Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs
IF Dunn et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Thrombospondin-1 is downregulated by anoxia and suppresses tumorigenicity of human glioblastoma cells
M Tenan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging
DA Sipkins et al.
JOURNAL OF NEUROIMMUNOLOGY (2000)
Expression of structural proteins and angiogenic factors in cerebrovascular anomalies
T Kiliç et al.
NEUROSURGERY (2000)
Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin
S Bredow et al.
EUROPEAN JOURNAL OF CANCER (2000)
Mechanisms of angiogenesis and arteriogenesis
P Carmeliet
NATURE MEDICINE (2000)
Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion
TN Lin et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease
S Richard et al.
NEUROSURGICAL REVIEW (2000)
Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: A quantitative multi-parameter analysis
PFJW Rijken et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2000)
Share Paper
